Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgical Innovations GroupLSE:SUN PB Ratio is 0.63 as of Jul. 20, 2026, which is 58% below its 10-year median of 1.50. The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Surgical Innovations Group ranks better than 89.57% on this metric.
The historical rank and industry rank for Surgical Innovations Group's PB Ratio or its related term are showing as below:
LSE:SUN'
s PB Ratio Range Over the Past 10 Years
Min: 0.39 Med: 1.5 Max: 5.31
Current: 0.63
During the past 13 years, Surgical Innovations Group's highest PB Ratio was 5.31. The lowest was 0.39. And the median was 1.50.
LSE:SUN's PB Ratio is ranked better than 89.57% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs LSE:SUN: 0.63
During the past 12 months, Surgical Innovations Group's average Book Value Per Share Growth Rate was -11.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -12.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -3.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Surgical Innovations Group was 141.70% per year. The lowest was -68.40% per year. And the median was 6.65% per year.
Back to Basics: PB Ratio
Surgical Innovations Group (LSE:SUN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Surgical Innovations Group PB Ratio Related Terms
Surgical Innovations Group PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surgical Innovations Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Surgical Innovations Group (LSE:SUN) has a PB Ratio of 0.63 as of Jul. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Surgical Innovations Group and its competitors. This is 58% below median its historical median of 1.50. Over the past decade, Surgical Innovations Group's PB Ratio has ranged from 0.39 to 5.31. According to the industry distribution chart, Surgical Innovations Group ranks #82 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 10.4%.
Is Surgical Innovations Group's PB Ratio too high?
Surgical Innovations Group's current PB Ratio of 0.63 is 58% below median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 5.31. The Medical Devices & Instruments industry median PB Ratio is 2.04. Surgical Innovations Group's value of 0.63 is 69.1% below this industry median. Based on the distribution chart, Surgical Innovations Group ranks #82 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Surgical Innovations Group's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #82 out of 786 companies for PB Ratio. This places Surgical Innovations Group in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. Surgical Innovations Group's value of 0.63 is 69.1% below this benchmark. Historically, Surgical Innovations Group's own PB Ratio has ranged from 0.39 to 5.31 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 2.04, Surgical Innovations Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current PB Ratio of 0.63 is 69.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current PB Ratio is 0.63, which is 58% below median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.01 — trading 50% below its estimated fair value. The current PB Ratio is 0.63, which is 58% below median its 10-year median of 1.50 and 69.1% below the Medical Devices & Instruments industry median of 2.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current PB Ratio is 0.63 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 
